Human Rhinovirus Infections

Human Respiratory Viral Infections

Volumn , Issue , 2014, Pages 353-376

  Greenberg, Stephen B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84982689379     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16778-20     Document Type: Chapter

References (231)

1. Greenberg SB. Update on rhinovirus and coronavirus infections. Semin Respir Crit Care Med 2011; 32: 433-446.
2. Kennedy JL, Turner RB, Braciale T, Heymann PW, Borish L. Pathogenesis of rhinovirus infection. Curr Opin Virol 2012; 2: 287-293.
3. Jacobs SE, Lamson DM, St George K, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev 2013; 26: 135-162.
4. Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994; 330: 25-30.
5. Gwaltney JM Jr, Winther B, Patrie JT, Hendley JO. Combined antiviral-antimediator treatment for the common cold. J Infect Dis 2002; 186: 147-154.
6. Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778-782.
7. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 167-173.
8. El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB. Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clin Infect Dis 2000; 31: 96-100.
9. Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 115-120.
10. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ1995; 310: 1225-1229.
11. Hiatt PW, Grace SC, Kozinetz CA et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999; 103: 619-626.
12. Chonmaitree T, Howie VM, Truant AL. Presence of respiratory viruses in middle ear fluids and nasal wash specimens from children with acute otitis media. Pediatrics 1986; 77: 698-702.
13. Pitkaranta A, Virolainen A, Jero J, Arruda E, Hayden FG. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics 1998; 102: 291-295.
14. Price WH. The isolation of a new virus associated with respiratory clinical disease in humans. Proc Natl Acad Sci USA 1956; 42: 892-896.
15. Arden KE, Mackay IM. Human rhinoviruses: Coming in from the cold. Genome Med 2009; 1: 44.
16. Hayden FG. Rhinovirus and the lower respiratory tract. Rev Med Virol 2004; 14: 17-31.
17. Palmenberg AC, Spiro D, Kuzmickas R et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 2009; 324: 55-59.
18. ICTV HRV C proposal. http://talk.ictvonline.org/media/p/1201.aspx30August2009.
19. Blomqvist S, Savolainen C, Råman L, Roivainen M, Hovi T. Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J Clin Microbiol 2002; 40: 4218-4223.
20. Lee W-M, Kiesner C, Pappas T et al. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illness in infants. PLoS One 2007; 2: e966.
21. Bochkov YA, Gern JE. Clinical and molecular features of human rhinovirus C. Microbes Infect 2012; 14: 485-494.
22. Fuchs R, Blaas D. Productive entry pathways of human rhinoviruses. Adv Virol 2012; 2012: 826301.
23. Roy A, Post CB. Long-distance correlations of rhinovirus capsid dynamics contribute to uncoating and antiviral activity. Proc Natl Acad Sci USA 2012; 109: 5271-5276.
24. Rahamat-Langendoen J, Riezebos-Brilman A, Borger R et al. Up surge of human enterovirus 68 infections in patients with severe respiratory tract infections. J Clin Virol 2011; 52: 103-106.
25. Tapparel C, Junier T, Germann D et al. New respiratory enterovirus and recombinant rhinoviruses among circulating strains. Emerg Infect Dis 2009; 15: 719-726.
26. Hasegawa S, Hirano R, Okamoto-Nakagawa R, Ichiyama T, Shirabe K. Enterovirus 68 infection in children with asthma attacks: Virus-induced asthma in Japanese children. Allergy 2011; 66: 1618-1620.
27. Imamura T, Fuji N, Suzuki A et al. Enterovirus 68 among children with severe acute respiratory infection, the Philippines. Emerg Infect Dis 2011; 17: 1430-1435.
28. Jacques J, Moret H, Minette D et al. Epidemiological, molecular, and clinical features of enterovirus respiratory infections in French children between 1999 and 2005. J Clin Microbiol 2008; 46: 206-213.
29. Piralla A, Lilleri D, Sarasini A et al. Human rhinovirus and human respiratory enterovirus (EV68 and EV104) infections in hospitalized patients in Italy, 2008-2009. Diagn Microbiol Infect Dis 2012; 73: 162-167.
30. Jaramillo-Gutierrez G, Benschop KS, Claas EC et al. September through October 2010 multi-centre study in the Netherlands examining laboratory ability to detect enterovirus 68, an emerging respiratory pathogen. J Virol Methods 2013. pii: S0166-0934(13)00059-1.
31. Johnston SL. Overview of virus-induced airway disease. Proc Am Thorac Soc 2005; 2: 150-156.
32. Jarjour NN, Gern JE, Kelly EA, Swenson CA, Dick CR, Busse WW. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000; 105: 1169-1177.
33. Johnston SL, Papi A, Bates PJ, Mastronarde JG, Monick MM, Hunninghake GW. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 1998; 160: 6172-6181.
34. Laza-Stanca V, Stanciu LA, Message SD, Edwards MR, Gern JE, Johnston SL. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J Virol 2006; 80: 8248-8258.
35. Griego SD, Weston CB, Adams JL, Tal-Singer R, Dillon SB. Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol 2000; 165: 5211-5220.
36. Ishizuka S, Yamaya M, Suzuki T et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis 2003; 188: 1928-1939.
37. Kim JH, Kwon HJ, Jang YJ. Effects of rhinovirus infection on the expression and function of cystic fibros is transmembrane conduct ance regulator and epithelial sodium channel in human nasal mucosa. Ann Allergy Asthma Immunol 2012; 108: 182-187.
38. Miller EK, Hernandez JZ, Wimmenauer V et al. A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med 2012; 185: 508-516.
39. Vareille M, Kieninger E, Alves MP et al. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Thorax 2012; 67: 517-525.
40. Peltola V, Waris M, Kainulainen L, Kero J, Ruuskanen O. Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia. Clin Microbiol Infect 2013 Jul; 19(7): E322-E327.
41. Niespodziana K, Napora K, Cabauatan C et al. Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. FASEB J 2012; 26: 1001-1008.
42. Gern JE, Dick EC, Kelly EA, Vrtis R, Klein B. Rhinovirus-specific T cells recognize both shared and serotype-restricted viral epitopes. J Infect Dis 1997; 175: 1108-1114.
43. Arruda E, Pitkaranta A, Witek TJ Jr, Doyle CA, Hayden FG. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol 1997; 35: 2864-2868.
44. Makela MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 1998; 36: 539-542.
45. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33: 757-762.
46. Hendley JO, Gwaltney JM Jr. Mechansims of transmission of rhinovirus infections. Epidemiol Rev 1988; 10: 243-258.
47. McErlean P, Shackleton LA, Andrewes E et al. Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C). PloS One 2008; 3: e1847.
48. Miller EL, Khuri-Bulos N, Williams JV et al. Human rhinovirus C associated with wheezing in hospitalized children in the Middle East. J Clin Virol 2009; 46: 85-99.
49. Renwick N, Schweiger B, Kapoor V et al. A recently identified rhinovirus genotype is associated with severe respiratory-Tract infection in children in Germany. J Infect Dis 2007; 196: 1754-1760.
50. Savolainen-Kopra C, Blomqvist S, Kilpi T, Roivainen M, Hovi T. Novel species of human rhinoviruses in acute otitis media. Pediatr Infect Dis J 2009; 28: 59-61.
51. Linsuwanon P, Payungporn S, Samransamruajkit R et al. High prevalence of human rhinovirus C infection in Thai children with acute lower respiratory tract disease. J Infect 2009; 59: 115-121.
52. Tapparel C, L’Huillier AG, Rougemont AL, Beghetti M, Barazzone-Argiroffo C, Kaiser L. Pneumonia and pericarditis in a child with HRV-C infection: A case report. J Clin Virol 2009; 45: 157-160.
53. Canducci F, Debiaggi M, Ceresola ER et al. Infection and coinfection of human rhinovirus C in stem cell transplant recipients. Clin Dev Immunol 2013; 2013: 236081.
54. Khetsuriani N, Lu X, Teague WG, Kazerouni N, Anderson LJ, Erdmann DD. Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis 2008; 14: 1793-1796.
55. Kneider M, Bergstrom T, Gustafsson C et al. Sequence analysis of human rhinovirus aspirated from the nasopharynx of patients with relapsing-remitting MS. Mult Scler 2009; 15: 437-442.
56. Miller EK, Edwards KM, Weinberg GA et al. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 2009; 123: 98-104.
57. Alper CM, Winther B, Mandel EM, Hendley JO, Doyle WJ. Rate of concurrent otitis media in upper respiratory tract infections with specific viruses. Arch Otolaryngol Head Neck Surg 2009; 135: 17-21.
58. Urquhart GED, Grist NR. Virological studies of sudden, unexplained infant deaths in Glasgow 1967-1970. J Clin Pathol 1972; 25: 443-446.
59. Xatzipsalti M, Kyrana S, Tsolia M et al. Rhinovirus viremia in children with respiratory infections. Am J Resp Crit Care Med 2005; 172: 1037-1040.
60. Jartti T, Lehtinen P, Vuorinen P, Koskenvuo M, Ruuskanen O. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 2004; 72: 695-699.
61. Winther B, Hayden FG, Hendley JO. Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season. J Med Virol 2006; 78: 644-650.
62. Cate TR, Couch RB, Johnson KM. Studies with rhinoviruses in volunteers: Production of illness, effect of naturally acquired antibody, and demonstration of a protective effect not associated with serum antibody. J Clin Investig 1964; 43: 56-67.
63. van Elden LJ, van Loon AM, Haarman M et al. Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract. J Clin Virol 2008; 41: 116-121.
64. Hendley JO, Gwaltney JM Jr. Viral titers in nasal lining fluid compared to viral titers in nasal washes during experimental rhinovirus infection. J Clin Virol 2004; 30: 326-328.
65. Dick EC, Blumer CR, Evans AS. Epidemiology of infections with rhinovirus types 43 and 55 in a group of university of Wisconsin student families. Am J Epidemiol 1967; 86: 386-400.
66. Piralla A, Rovida F, Campanini G et al. Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. J Clin Virol 2009; 45: 311-317.
67. Huang T, Wang W, Bessaud M et al. Evidence of recombination and genetic diversity in human rhinoviruses in children with acute respiratory infection. PLoS One 2009; 4: e6355.
68. Dominguez SR, Briese T, Palacios G et al. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol 2008; 43: 219-222.
69. Savolainen C, Mulders MN, Hovi T. Phylogenetic analysis of rhinovirus isolates collected during successive epidemic seasons. Vir Res 2002; 85: 41-46.
70. Linder JE, Kraft DC, Mohamed Y et al. Human rhinovirus C: Age, season, and lower respiratory illness over the past 3 decades. J Allergy Clin Immunol 2013; 131: 69-77.
71. Mackay IM, Lambert SB, Faux CE et al. Community-wide, contemporaneous circulation of a broad spectrum of human rhinoviruses in healthy Australian preschool-aged children during a 12-month period. J Infect Dis 2013; 207: 1433-1441.
72. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325: 606-612.
73. Cohen S, Janicki-Deverts D, Turner RB et al. Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults. JAMA. 2013; 309: 699-705.
74. Cohen S, Janicki-Deverts D, Doyle WJ et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci USA 2012; 109: 5995-5999.
75. Proud D, Hudy MH, Wiehler S et al. Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genes. PLoS One 2012; 7: e40762.
76. Venarske DL, Busse WW, Griffin MR et al. The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis 2006; 193: 1536-1543.
77. Meerhoff TJ, Houben ML, Coenjaerts FE et al. Detection of multiple respiratory pathogens during primary respiratory infection: Nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction. Eur J Clin Microbiol Infect Dis 2010; 29: 365-371.
78. Chandrasekaran A, Manji R, Joseph A, Zhang F, Ginocchio CC. Broad reactivity of the Luminex xTAG Respiratory Virus Panel (RVP) assay for the detection of human rhinoviruses. J Clin Virol 2012; 53: 272-273.
79. Jokela P, Piiparinen H, Mannonen L, Auvinen E, Lappalainen M. Performance of the Luminex xTAG Respiratory Viral Panel Fast in a clinical laboratory setting. J Virol Methods 2012; 182: 82-86.
80. Forman MS, Advani S, Newman C, Gaydos CA, Milstone AM, Valsamakis A. Diagnostic performance of two highly multiplexed respiratory virus assays in a pediatric cohort. J Clin Virol 2012; 55: 168-172.
81. Babady NE, Mead P, Stiles J et al. Comparison of the Luminex xTAG RVP Fast assay and the Idaho Technology FilmArray RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital. J Clin Microbiol 2012; 50: 2282-2288.
82. Hammond SP, Gagne LS, Stock SR et al. Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods. J Clin Microbiol 2012; 50: 3216-3221.
83. Rand KH, Rampersaud H, Houck HJ. Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVP. J Clin Microbiol 2011; 49: 2449-2453.
84. Loeffelholz MJ, Pong DL, Pyles RB et al. Comparison of the FilmArray respiratory panel and prodesse real-time PCR assays for detection of respiratory pathogens. J Clin Microbiol 2011; 49: 4083-4088.
85. Gwaltney JM Jr, Hendley JO, Patrie JT. Symptom severity patterns in experimental common colds and their usefulness in timing onset of illness in natural colds. Clin Infect Dis 2003; 36: 714-723.
86. Harris JM 2nd, Gwaltney JM Jr. Incubation periods of experimental rhinovirus infection and illness. Clin Infect Dis 1996; 23: 1287-1290.
87. Hombrouck A, Sabbe M, Van Casteren V et al. Viral aetiology of influenza-like illness in Belgium during the influenza A (H1N1) 2009 pandemic. Eur J Clin Microbiol Infect Dis 2012; 31: 999-1007.
88. Schnepf N, Resche-Rigon M, Chaillon A et al. High burden of non-influenza viruses in influenza-like illness in the early weeks of H1N1v epidemic in France. PLoSOne 2011; 6: e23514.
89. Memish ZA, Assiri AM, Alshehri M, Hussain R, Alomar I. The prevalence of respiratory viruses among health care workers serving pilgrims in Makkah during the 2009 influenza A (H1N1) pandemic. Travel Med Infect Dis 2012; 10: 18-24.
90. Pascalis H, Temmam S, Turpin M et al. Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: A cohort study in Reunion Island. PLoS ONE 2012; 7: e44755.
91. Chang ML, Jordan-Villegas A, Evans A et al. Respiratory viruses identified in an urban children’s hospital emergency department during the 2009 influenza A(H1N1) pandemic. Pediatr Emerg Care 2012; 28: 990-997.
92. Thiberville SD, Ninove L, VuHai V et al. The viral etiology of an influenza-like illness during the 2009 pandemic. J Med Virol 2012; 84: 1071-1079.
93. Yang Y, Wang Z, Ren L et al. Influenza A/H1N1 2009 pandemic and respiratory virus infections, Beijing, 2009-2010. PLoS One 2012; 7: e45807.
94. Nisii C, Meschi S, Selleri M et al. Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection. J Clin Microbiol 2010; 48: 3383-3385.
95. Kraft CS, Jacob JT, Sears MH, Burd EM, Caliendo AM, Lyon GM. Severity of human rhinovirus infection in immunocompromised adults is similar to that of 2009 H1N1 influenza. J Clin Microbiol 2012; 50: 1061-1063.
96. Atmar RL, Guy E, Guntupalli KK et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998; 158: 2453-2459.
97. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307: 982-986.
98. Xiang Z, Gonzalez R, Xie Z et al. Human rhinovirus group C infection in children with lower respiratory tract infection. Emerg Infect Dis 2008; 14: 1665-1667.
99. Grunberg K, Timmers MC, deKlerk EP, Dick EC, Sterk PJ. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 1999; 160: 1375-1380.
100. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994; 94: 2200-2208.
101. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995; 151: 879-886.
102. Papadopoulos NG, Bates PJ, Bardin PG et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181: 1875-1884.
103. Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155: 1159-1161.
104. Zhu Z, Tang W, Gwaltney JM Jr, Wu Y, Elias JA. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: Role of NF-kappaB. Am J Physiol 1997; 273: L814-L824.
105. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Resp Crit Care Med 2000; 162: 2226-2231.
106. Zhu Z, Tang W, Ray A et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest 1996; 97: 421-430.
107. Wark PA, Johnston SL, Bucchieri F et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201: 937-947.
108. Message SD, Laza-Stanca V, Mallia P et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci USA 2008; 105: 13562-13567.
109. Forbes RL, Gibson PG, Murphy VE, Wark PA. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax 2012; 67: 209-214.
110. Schneider D, Hong JY, Bowman ER et al. Macrophage/epithelial cell CCL2 contributes to rhinovirus-induced hyperresponsiveness and inflammation in a mouse model of allergic airways disease. Am J Physiol Lung Cell Mol Physiol 2013; 304: L162-L169.
111. Bartlett NW, Slater L, Glanville N et al. Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus. EMBO Mol Med 2012; 4: 1244-1260.
112. Contoli M, Message SD, Laza-Stanca V et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12: 1023-1026.
113. Durrani SR, Montville DJ, Pratt AS et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol 2012; 130: 489-495.
114. Heymann PW, Kennedy JL. Rhinovirus-induced asthma exacerbations during childhood: The importance of understanding the atopic status of the host. J Allergy Clin Immunol 2012; 130: 1315-1316.
115. Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev Microbiol 2012; 10: 459-471.
116. Beigelman A, Bacharier LB. The role of early life viral bronchiolitis in the inception of asthma. Curr Opin Allergy Clin Immunol 2013; 13: 211-216.
117. Piotrowska Z, Vázquez M, Shapiro ED et al. Rhinoviruses are a major cause of wheeling and hospitalization in children less than 2 years of age. Pediatr Infect Dis J 2009; 28: 25-29.
118. Chung JY, Han TH, Kim SW, Kim CK, Hwang ES. Detection of viruses identified recently in children with acute wheezing. J Med Virol 2007; 79: 1238-1243.
119. Gangnon RE, Evans MD, Roberg KA et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178: 667-672.
120. Lemanske RF Jr, Jackson DJ, Gangnon RE et al. Rhinovirus illnesses during in fancy predict subsequent child hood wheezing. J Allergy Clin Immunol 2005; 116: 571-577.
121. Kim WK, Gern JE. Updates in the relationship between human rhinovirus and asthma. Allergy Asthma Immunol Res 2012; 4: 116-121.
122. Jackson DJ, Evans MD, Gangnon RE et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012; 185: 281-285.
123. Denlinger LC, Sorkness RL, Lee WM et al. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation. Am J Respir Crit Care Med 2011; 184: 1007-1014.
124. Calişkan M, Bochkov YA, Kreiner-Møller E et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013. [Epub ahead of print]
125. James KM, Peebles RS Jr, Hartert TV. Response to infections in patients with asthma and atopic disease: An epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol 2012; 130(2): 343-351.
126. Seemungal T, Harper-Owen R, Bhowmik A et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618-1623.
127. Rohde G, Wiethege A, Borg I et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: A case-control study. Thorax 2003; 58: 37-42.
128. Ko FW, Ip M, Chan PK et al. Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 2007; 132: 900-908.
129. Beckham JD, Cadena A, Lin J et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 2005; 50: 322-330.
130. Perotin JM, Dury S, Renois F et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: A pilot prospective study. J Med Virol 2013; 85: 866-873.
131. Kherad O, Kaiser L, Bridevaux PO et al. Upper respiratory infection, biomarkers and COPD exacerbations. Chest 2010; 138: 896-904.
132. Sajjan US, Jia Y, Newcomb DC et al. H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J 2006; 20: 2121-2123.
133. Mallia P, Message SD, Gielen V et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2011; 183: 734-742.
134. Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev 2003; 16: 230-241.
135. Bulut Y, Güven M, Otlu B et al. Acute otitis media and respiratory viruses. Eur J Pediatr 2007; 166: 223-228.
136. McBride TP, Doyle WJ, Hayden FG, Gwaltney JM Jr. Alterations of the Eustachian tube, middle ear, and nose in rhinovirus infection. Arch Otolaryngol Head Neck Surg. 1989; 115: 1054-1059.
137. Chantzi FM, Papadopoulos NG, Bairamis T et al. Human rhinoviruses in otitis media with effusion. Pediatr Allergy Immunol 2006; 17: 514-518.
138. Wiertsema SP, Chidlow GR, Kirkham LA et al. High detection rates of nucleic acids of a wide range of respiratory viruses in the nasopharynx and the middle ear of children with a history of recurrent acute otitis media. J Med Virol 2011; 83: 2008-2017.
139. Pitkaranta A, Roivainen M, Blomgren K et al. Presence of viral and bacterial pathogens in the nasopharynx of otitis-prone children. A prospective study. Int J Pediatr Otorhinolaryngol 2006; 70: 647-654.
140. Chonmaitree T, Revai K, Grady JJ et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis 2008; 46: 815-823.
141. Rihkanen H, Carpen O, Roivainen M, Vaheri A, Pitkaranta A. Rhinovirus in adenoid tissue. Int J Pediatr Otorhinolaryngol 2004; 68: 903-908.
142. Elkhatieb A, Hipskind G, Woerner D, Hayden FG. Middle ear abnormalities during natural rhinovirus colds in adults. J Infect Dis 1993; 168: 618-621.
143. Turner BW, Cail WS, Hendley JO et al. Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus colds. J Allergy Clin Immunol 1992; 90: 474-478.
144. Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23:1209-1223.
145. Pitkaranta A, Arruda E, Malmberg H, Hayden FG. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR. J Clin Microbiol 1997; 35: 1791-1793.
146. Gwaltney JM Jr, Hendley JO, Phillips CD, Bass CR, Mygind N, Winther B. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 2000; 30: 387-391.
147. Falsey AR, Walsh EE, Hayden FG. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J Infect Dis 2002; 185: 1338-1341.
148. Franz A, Adams O, Williems R et al. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infections. J Clin Virol 2010; 48: 239-245.
149. Marcos MA, Esperatti M, Torres A. Viral pneumonia. Current Opin Infect Dis 2009; 22: 143-147.
150. Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in developing country. Pediatr Infect Dis J 2009; 27: 939-941.
151. Cilla G, Oñate E, Perez-Yarza, EG et al. Viruses in community-acquired pneumonia in children aged less than 3 years old: High rate of viral coinfection. J Med Virol 2008; 80: 1843-1839.
152. Hamano-Hasegawa K, Morozumi M, Nakayama E et al; Acute Respiratory Diseases Study Group. Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemother 2008; 14: 424-432.
153. Louie JK, Roy-Burman A, Guardia-Labor L et al. Rhinovirus associated with severe lower respiratory tract infections in children. Pediatr Infect Dis J 2009; 28: 337-339.
154. Lu G, Li J, Xie Z et al. Human metapneumovirus associated with community-acquired pneumonia in children in Beijing, China. J Med Virol 2013; 85: 138-143.
155. Launes C, de-Sevilla MF, Selva L, Garcia-Garcia JJ, Pallares R, Muñoz-Almagro C. Viral coinfection in children less than five years old with invasive pneumococcal disease. Pediatr Infect Dis J 2012; 31: 650-653.
156. Choi SH, Hong SB, Ko GB et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012; 186: 325-332.
157. García-García ML, Calvo C, Pozo F, Villadangos PA, Pérez-Breña P, Casas I. Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J 2012; 31: 808-813.
158. Miller EK, Bugna J, Libster R et al. Human rhinoviruses in severe respiratory disease in very low birth weight infants. Pediatrics 2012; 129: e60-e67.
159. Esposito S, Daleno C, Tagliabue C et al. Impact of rhinoviruses on pediatric community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2012; 31: 1637-1645.
160. Homaira N, Luby SP, Petri WA et al. Incidence of respiratory virus-associated pneumonia in urban poor young children of Dhaka, Bangladesh, 2009-2011. PLoS One 2012; 7: e32056.
161. Guerrier G, Goyet S, Chheng ET et al. Acute viral lower respiratory tract infections in Cambodian children: Clinical and epidemiologic characteristics. Pediatr Infect Dis J 2013; 32: e8-e13.
162. Cho HJ, Shim SY, Son DW, Sun YH, Tchah H, Jeon IS. Respiratory viruses in neonates hospitalized with acute lower respiratory tract infections. Pediatr Int 2013; 55: 49-53.
163. Suzuki A, Lupisan S, Furuse Y et al. Respiratory viruses from hospitalized children with severe pneumonia in the Philippines. BMC Infect Dis 2012; 12: 267.
164. Uršič T, Jevšnik M, Zigon N et al. Human bocavirus and other respiratory viral infections in a 2-year cohort of hospitalized children. J Med Virol 2012; 84: 99-108.
165. Pretorius MA, Madhi SA, Cohen C et al. Respiratory viral coinfections identified by a 10-plexreal-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness-South Africa, 2009-2010. J Infect Dis 2012; 206 Suppl 1: S159-S165.
166. Chidlow GR, Laing IA, Harnett GB et al. Respiratory viral pathogens associated with lower respiratory tract disease among young children in the highlands of Papua New Guinea. J Clin Virol 2012; 54: 235-239.
167. Ghani AS, Morrow BM, Hardie DR, Argent AC. An investigation into the prevalence and outcome of patients admitted to a pediatric intensive care unit with viral respiratory tract infections in Cape Town, South Africa. Pediatr Crit Care Med 2012; 13: e275-e281.
168. Chen YW, Huang YC, Ho TH, Huang CG, Tsao KC, Lin TY. Viral etiology of bronchiolitis among pediatric in patients in northern Taiwan with emphasis on newly identified respiratory viruses. J Microbiol Immunol Infect 2012. pii: S1684-1182(12)00173-9.
169. Antunes H, Rodrigues H, Silva N et al. Etiology of bronchiolitis in a hospitalized pediatric population: Prospective multicenter study. J Clin Virol 2010; 48: 134-136.
170. Mansbach JM, Piedra PA, Teach SJ et al; MARC-30 Investigators. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 2012; 166: 700-706.
171. Camps Serra M, Cervera C, Pumarola T et al. Virological diagnosis in community-acquired pneumonia in immunocompromised patients. Eur Respir J 2008; 31: 618-624.
172. Templeton KE, Scheltinga SA, Van den Eeden WC et al. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005; 41: 345-351.
173. Ko FW, Ip M, Chan PK et al. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia. Respir Med 2008; 102(8): 1109-1116.
174. Jennings LC, Anderson TP, Beynon KA et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008; 63: 42-48.
175. Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection in adults hospitalized with community-acquired pneumonia: Prevalence, pathogens, and presentation. Chest 2008; 134: 1141-1148.
176. Diederen BM, Van Der Eerden MM, Vlaspolder F et al. Detection of respiratory virases and Legionella spp. by real-time polymerase chain reaction in patients with community-acquired pneumonia. Scand J Infect Dis 2009; 41: 45-50.
177. Lieberman D, Shimoni A, Shemer-Avni Y, Keren-Naos A, Shtainberg R, Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest 2010; 138: 811-816.
178. Stempel HE, Martin ET, Kuypers J, Englund JA, Zerr DM. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr 2009; 98: 123-126.
179. Midulla F, Scagnolari C, Bonci E et al. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 2010; 95: 35-41.
180. Freymuth F, Vabret A, Dina J et al. Bronchiolitis viruses. Arch Pediatr 2010; 17: 1192-1201.
181. Collinson J, Nicholson KG, Cancio E et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 1996; 51: 1115-1122.
182. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995; 73: 117-120.
183. Olesen HV, Nielsen LP, Schiotz PO. Viral and a typical bacterial infections in the out patient pediatric cystic fibrosis clinic. Pediatr Pulmonol 2006; 41: 1197-1204.
184. Wat D, Gelder C, Hibbitts S et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008; 7: 320-328.
185. de Almeida MB, Zerbinati RM, Tateno AF et al. Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. Emerg Infect Dis 2010; 16: 996-999.
186. Garbino J, Gerbase MW, Wunderli W et al. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients. Chest 2004; 125: 1033-1039.
187. Ison MG, Hayden FG, Kaiser L, Corey L, Boeckh M. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis 2003; 36: 1139-1143.
188. Hassan IA, Chopra R, Swindell R, Mutton KJ. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: The Christie hospital experience. Bone Marrow Transplant 2003; 32: 73-77.
189. Ljungman P, Ward KN, Crooks BN et al. Respiratory virus infections after stem cell transplantation: A prospective study from the infectious diseases working party of the European Group for blood and marrow transplantation. Bone Marrow Transplant 2001; 28: 479-484.
190. Ghosh S, Champlin R, Couch R et al. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis 1999; 29: 528-532.
191. Milano F, Campbell AP, Guthrie KA et al. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood 2010; 115: 2088-2094.
192. Ohrmalm L, Wong M, Aust C et al. Viral findings in adult hematological patients with neutropenia. PLoS One 2012; 7: e36543.
193. Torres JP, Labraña Y, Ibañez C et al. Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia. Pediatr Infect Dis J 2012; 31: 889-893.
194. Valenti WM, Clarke TA, Hall CB, Menegus MA, Shapiro DL. Concurrent out breaks of rhinovirus and respiratory syncytial virus in anintensive care nursery: Epidemiology and associated risk factors. J Pediatr 1982; 100: 722-776.
195. Reid AB, Anderson TL, Cooley L, Williamson J, Mcgregor AR An outbreak of human rhinovirus species C infections in a neonatal intensive care unit. Pediatr Infect Dis J 2011; 30(12): 1096-1098.
196. vanPiggelen RO, vanLoon AM, Krediet TG, Verboon-Maciolek MA. Human rhinovirus causes severe infection in preterm infants. Pediatr Infect Dis J 2010; 29: 364-365.
197. Longtin J, Marchand-Austin A, Winter AL et al. Rhinovirus outbreaks in long-term care facilities, Ontario, Canada. Emerg Infect Dis 2010; 16: 1463-1465.
198. Wald TG, Shult P, Krause P, Miller BA, Drinka P, Gravenstein S. A rhinovirus outbreak among residents of a long-term care facility. Ann Intern Med 1995; 123: 588-593.
199. Longtin J, Winter AL, Heng D et al. Severe human rhinovirus outbreak associated with fatalities in a long-term care facility in Ontario, Canada. J Am Geriatr Soc 2010; 58: 2036-2038.
200. Louie JK, Yagi S, Nelson FA et al. Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality. Clin Infect Dis 2005; 41: 262-265.
201. Hicks LA, Shepard CW, Britz PH et al. Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus. J Am Geriatr Soc 2006; 54: 284-289.
202. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35: S65-S164.
203. Eccles R. Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther 2006; 31: 309-319.
204. Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev 2004; 2: CD001728.
205. Rotbart HA. Antiviral therapy for enteroviruses and rhinoviruses. Antivir Chem Chemother 2000; 11: 261-271.
206. Hayden FG, Gwaltney JM Jr. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. J Infect Dis 1984; 150: 174-180.
207. Higgins PG, Phillpotts RJ, Scott GM, Wallace J, Bernhardt LL, Tyrrell DA. Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers. Antimicrob Agents Chemother 1983; 24: 713-715.
208. Sasaki T, Yamaya M, Yasuda H et al. The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. Eur J Pharmacol 2005; 509: 201-210.
209. Hayden FG, Herrington DT, Coats TL et al.; Pleconaril Respiratory Infection Study Group. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 2003; 36: 1523-1532.
210. Patick AK, Brothers MA, Maldonado F et al. In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 2005; 49: 2267-2275.
211. Hayden FG, Turner RB, Gwaltney JM et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 2003; 47: 3907-3916.
212. Kang EJ, Kim SY, Hwang IH, Ji YJ. The effect of probiotics on prevention of common cold: A meta-analysis of randomized controlled trial studies. Korean J Fam Med 2013; 34: 2-10.
213. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013; 1: CD000980.
214. Schoop R, Klein P, Suter A, Johnston SL. Echinacea in the prevention of induced rhinovirus colds: A meta-analysis. Clin Ther 2006; 28: 174-183.
215. Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto AS. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin Infect Dis 2004; 38:1367-1371.
216. Turner RB. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin Infect Dis 2001; 33: 1865-1870.
217. Kurugöl Z, Akilli M, Bayram N, Koturoglu G. The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children. Acta Paediatr 2006; 95: 1175-1181.
218. Van Ly D, King NJ, Moir LM, Burgess JK, Black JL, Oliver BG. Effects of β(2) Agonists, corticosteroids, and novel therapies on rhinovirus-induced cytokine release and rhinovirus replication in primary airway fibro blasts. J Allergy (Cairo) 2011: 457169.
219. Hayward G, Thompson MJ, Perera R, Del Mar CB, Glasziou PP, Heneghan CJ. Corticosteroids for the common cold. Cochrane Database Syst Rev 2012 Aug 15; 8: CD008116.
220. Kloepfer KM, DeMore JP, Vrtis RF et al. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16. Ann Allergy Asthma Immunol 2011; 106: 252-257.
221. Min JY, Shin SH, Kwon HJ, Jang YJ. Levocetirizine inhibits rhinovirus-induced bacterial adhesion to nasal epithelial cells through down-regulation of cell adhesion molecules. Ann Allergy Asthma Immunol 2012; 108: 44-48.
222. Ganesan S, Faris AN, Comstock AT et al. Quercetin inhibits rhinovirus replication in vitro and in vivo. Antiviral Res 2012; 94: 258-271.
223. Yamaya M, Nishimura H, Hatachi Y et al. Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Antimicrob Agents Chemother 2012; 56: 4052-4061.
224. Min JY, Jang YJ. Macrolide therapy in respiratory viral infections. Mediators Inflamm 2012; 2012: 649570.
225. Turner RB, Hendley JO. Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother 2005; 56: 805-807.
226. Turner RB, Biedermann KA, Morgan JM, Keswick B, Ertel KD, Barker MF. Efficacy of organic acids in hand cleansers for prevention of rhinovirus infections. Antimicrob Agents Chemother 2004; 48: 2595-2598.
227. Savolainen-Kopra C, Korpela T, Simonen-Tikka ML et al. Single treatment with ethanol hand rub is ineffective against human rhinovirus-Hand washing with soap and water removes the virus efficiently. J Med Virol 2012; 84: 543-547.
228. McLean GR, Walton RP, Shetty S et al. Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1. Antiviral Res 2012; 95: 193-201.
229. Baines KJ, Hsu AC, Tooze M et al. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Respiratory Research 2013; 14: 15.
230. Granados A, Luinstra K, Chong S et al. Use of an improved quantitative polymerase chain reaction assay to determine differences in human rhinovirus viral loads in different populations. Diagnostic Microbiology and Infectious Disease 2012; 74(4): 384-387.
231. Gern JE. Rhinovirus and the initiation of asthma. Curr Opin Allergy Clin Immunol 2009; 9: 73-78.